146 related articles for article (PubMed ID: 26463566)
1. Transcriptional Profiling Identifies the Signaling Axes of IGF and Transforming Growth Factor-b as Involved in the Pathogenesis of Osteosarcoma.
Yang R; Piperdi S; Zhang Y; Zhu Z; Neophytou N; Hoang BH; Mason G; Geller D; Dorfman H; Meyers PA; Healey JH; Phinney DG; Gorlick R
Clin Orthop Relat Res; 2016 Jan; 474(1):178-89. PubMed ID: 26463566
[TBL] [Abstract][Full Text] [Related]
2. Reexpression of LSAMP inhibits tumor growth in a preclinical osteosarcoma model.
Barøy T; Kresse SH; Skårn M; Stabell M; Castro R; Lauvrak S; Llombart-Bosch A; Myklebost O; Meza-Zepeda LA
Mol Cancer; 2014 Apr; 13():93. PubMed ID: 24885297
[TBL] [Abstract][Full Text] [Related]
3. IR/IGF1R signaling as potential target for treatment of high-grade osteosarcoma.
Kuijjer ML; Peterse EF; van den Akker BE; Briaire-de Bruijn IH; Serra M; Meza-Zepeda LA; Myklebost O; Hassan AB; Hogendoorn PC; Cleton-Jansen AM
BMC Cancer; 2013 May; 13():245. PubMed ID: 23688189
[TBL] [Abstract][Full Text] [Related]
4. Effects of THBS3, SPARC and SPP1 expression on biological behavior and survival in patients with osteosarcoma.
Dalla-Torre CA; Yoshimoto M; Lee CH; Joshua AM; de Toledo SR; Petrilli AS; Andrade JA; Chilton-MacNeill S; Zielenska M; Squire JA
BMC Cancer; 2006 Oct; 6():237. PubMed ID: 17022822
[TBL] [Abstract][Full Text] [Related]
5. Comparison of Tumor- and Bone Marrow-Derived Mesenchymal Stromal/Stem Cells from Patients with High-Grade Osteosarcoma.
Le Nail LR; Brennan M; Rosset P; Deschaseaux F; Piloquet P; Pichon O; Le Caignec C; Crenn V; Layrolle P; Hérault O; De Pinieux G; Trichet V
Int J Mol Sci; 2018 Mar; 19(3):. PubMed ID: 29494553
[TBL] [Abstract][Full Text] [Related]
6. Hub biomarkers in ultrasound-guided bladder cancer and osteosarcoma: Myosin light chain kinase and caldesmon.
Li H; Lin G; Cui M; Wang L; Ding D; Li X; Fan X; Yang Q; Wang Y; Kang C; Zhang L; Liu B; Su J
Medicine (Baltimore); 2023 Dec; 102(48):e36414. PubMed ID: 38050320
[TBL] [Abstract][Full Text] [Related]
7. Carboxypeptidase Vitellogenic-Like Promotes the Proliferation and Metastasis of Osteosarcoma through the TGF-β/Smad Signaling Pathway.
Wang L; Piao L; Yuan X; Tong L; Han X; Wang J; Shi D; Shao S; Xu X; Zhuang M; Cheng D; Liu Z
Ann Clin Lab Sci; 2023 Nov; 53(6):890-904. PubMed ID: 38182149
[TBL] [Abstract][Full Text] [Related]
8. Expression and significance of Kruppel-like factor 6 gene in osteosarcoma.
Chen K; Chen Y; Zhu XD; Bai YS; Wei XZ; Wang CF; Chen ZQ; Li M
Int Orthop; 2012 Oct; 36(10):2107-11. PubMed ID: 22855058
[TBL] [Abstract][Full Text] [Related]
9. Expression analysis of genes associated with human osteosarcoma tumors shows correlation of RUNX2 overexpression with poor response to chemotherapy.
Sadikovic B; Thorner P; Chilton-Macneill S; Martin JW; Cervigne NK; Squire J; Zielenska M
BMC Cancer; 2010 May; 10():202. PubMed ID: 20465837
[TBL] [Abstract][Full Text] [Related]
10. Mitochondrial genome and functional defects in osteosarcoma are associated with their aggressive phenotype.
Jackson M; Serada N; Sheehan M; Srinivasan S; Mason N; Guha M; Avadhani N
PLoS One; 2018; 13(12):e0209489. PubMed ID: 30576337
[TBL] [Abstract][Full Text] [Related]
11. Proteomics and genomics insights on malignant osteosarcoma.
Kathiresan N; Selvaraj C; Pandian S; Subbaraj GK; Alothaim AS; Safi SZ; Kulathaivel L
Adv Protein Chem Struct Biol; 2024; 138():275-300. PubMed ID: 38220428
[TBL] [Abstract][Full Text] [Related]
12. Osteosarcoma PDX-Derived Cell Line Models for Preclinical Drug Evaluation Demonstrate Metastasis Inhibition by Dinaciclib through a Genome-Targeted Approach.
Schott CR; Koehne AL; Sayles LC; Young EP; Luck C; Yu K; Lee AG; Breese MR; Leung SG; Xu H; Shah AT; Liu HY; Spillinger A; Behroozfard IH; Marini KD; Dinh PT; Pons Ventura MV; Vanderboon EN; Hazard FK; Cho SJ; Avedian RS; Mohler DG; Zimel M; Wustrack R; Curtis C; Sirota M; Sweet-Cordero EA
Clin Cancer Res; 2024 Feb; 30(4):849-864. PubMed ID: 37703185
[TBL] [Abstract][Full Text] [Related]
13. Low expression of ZFP36L1 in osteosarcoma promotes lung metastasis by inhibiting the SDC4-TGF-β signaling feedback loop.
Ma M; Zhuang J; Li H; Mi R; Song Y; Yang W; Lu Y; Shen X; Wu Y; Shen H
Oncogene; 2024 Jan; 43(1):47-60. PubMed ID: 37935976
[TBL] [Abstract][Full Text] [Related]
14. Trophinin Is an Important Biomarker and Prognostic Factor in Osteosarcoma: Data Mining from Oncomine and the Cancer Genome Atlas Databases.
Cai P; Lu Y; Yin Z; Wang X; Zhou X; Li Z
Biomed Res Int; 2021; 2021():6885897. PubMed ID: 34307667
[TBL] [Abstract][Full Text] [Related]
15. Integration of single-cell sequencing and bulk expression data reveals chemokine signaling pathway in proliferating cells is associated with the survival outcome of osteosarcoma.
Yu L; Hongyu S; Yuxi C
BMC Med Genomics; 2023 Aug; 16(1):180. PubMed ID: 37537613
[TBL] [Abstract][Full Text] [Related]
16. Androgen receptor is a potential novel prognostic marker and oncogenic target in osteosarcoma with dependence on CDK11.
Liao Y; Sassi S; Halvorsen S; Feng Y; Shen J; Gao Y; Cote G; Choy E; Harmon D; Mankin H; Hornicek F; Duan Z
Sci Rep; 2017 Mar; 7():43941. PubMed ID: 28262798
[TBL] [Abstract][Full Text] [Related]
17. A novel classification predicts prognosis and drug sensitivity in osteosarcoma based on alterations in gene sets.
Ye S; Wang X; Chen R
Aging (Albany NY); 2024 Feb; 16(5):4579-4590. PubMed ID: 38428404
[TBL] [Abstract][Full Text] [Related]
18. Modeling phenotypic heterogeneity towards evolutionarily inspired osteosarcoma therapy.
Welch DL; Fridley BL; Cen L; Teer JK; Yoder SJ; Pettersson F; Xu L; Cheng CH; Zhang Y; Alexandrow MG; Xiang S; Robertson-Tessi M; Brown JS; Metts J; Brohl AS; Reed DR
Sci Rep; 2023 Nov; 13(1):20125. PubMed ID: 37978271
[TBL] [Abstract][Full Text] [Related]
19. The IL-17-IL-17RA axis is required to promote osteosarcoma progression in mice.
Yoshimura N; Kariya R; Shimada M; Tateyama M; Matsunaga H; Shibata Y; Tanimura S; Takata K; Arima T; Kawakami J; Maeda K; Fukuma Y; Uragami M; Ideo K; Sugimoto K; Yonemitsu R; Matsushita K; Hisanaga S; Yugami M; Uehara Y; Masuda T; Nakamura T; Tokunaga T; Karasugi T; Sueyoshi T; Sato H; Iwakura Y; Araki K; Kobayashi E; Okada S; Miyamoto T
Sci Rep; 2023 Dec; 13(1):21572. PubMed ID: 38062130
[TBL] [Abstract][Full Text] [Related]
20. Lipid Peroxidation-Related Redox Signaling in Osteosarcoma.
Borović Šunjić S; Jaganjac M; Vlainić J; Halasz M; Žarković N
Int J Mol Sci; 2024 Apr; 25(8):. PubMed ID: 38674143
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
